Ebrahim Rahmani Moghadam
Overview
Explore the profile of Ebrahim Rahmani Moghadam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jafaripour L, Naserzadeh R, Alizamani E, Javad Mashhadi S, Moghadam E, Nouryazdan N, et al.
Indian J Nephrol
. 2021 Aug;
31(3):218-224.
PMID: 34376933
Introduction: Methotrexate (MTX), used in the treatment of cancerous patients, causes toxicity in the different organs of the body. This study of rosmarinic acid (RA) is as an antioxidant on...
2.
Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam E, Hashemi F, et al.
Front Pharmacol
. 2020 Dec;
11:585413.
PMID: 33381035
Immune response, proliferation, migration and angiogenesis are juts a few of cellular events that are regulated by transforming growth factor-β (TGF-β) in cells. A number of studies have documented that...
3.
Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Moghadam E, Owrang M, et al.
Cell Signal
. 2020 Dec;
78:109871.
PMID: 33279671
Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and...
4.
Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Moghadam E, Raei M, et al.
ACS Comb Sci
. 2020 Oct;
22(12):669-700.
PMID: 33095554
Chemotherapy using natural compounds, such as resveratrol, curcumin, paclitaxel, docetaxel, etoposide, doxorubicin, and camptothecin, is of importance in cancer therapy because of the outstanding therapeutic activity and multitargeting capability of...
5.
Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam E, Hashemi F, Daneshi S, et al.
Curr Cancer Drug Targets
. 2020 Oct;
21(1):2-20.
PMID: 33069197
Brain tumors are responsible for high morbidity and mortality worldwide. Several factors such as the presence of blood-brain barrier (BBB), sensitive location in the brain, and unique biological features challenge...
6.
Moghadam E, Ang H, Asnaf S, Zabolian A, Saleki H, Yavari M, et al.
Biomolecules
. 2020 Sep;
10(10).
PMID: 32992587
Pharmacological profile of phytochemicals has attracted much attention to their use in disease therapy. Since cancer is a major problem for public health with high mortality and morbidity worldwide, experiments...
7.
Hushmandi K, Bokaie S, Hashemi M, Moghadam E, Raei M, Hashemi F, et al.
Eur J Pharmacol
. 2020 Sep;
887:173568.
PMID: 32956644
In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was...
8.
Ashrafizadeh M, Taeb S, Hushmandi K, Orouei S, Shahinozzaman M, Zabolian A, et al.
Pharmacol Res
. 2020 Aug;
161:105159.
PMID: 32818654
Transcription factors are potential targets in disease therapy, particularly in cancer. This is due to the fact that transcription factors regulate a variety of cellular events, and their modulation has...
9.
Ashrafizadeh M, Hushmandi K, Moghadam E, Zarrin V, Kashani S, Bokaie S, et al.
Bioengineering (Basel)
. 2020 Aug;
7(3).
PMID: 32784981
Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treatments. Patients with PCa are commonly diagnosed in advanced stages due to the lack...
10.
Ashrafizadeh M, Najafi M, Ang H, Moghadam E, Khaksary Mahabady M, Zabolian A, et al.
Biomedicines
. 2020 Aug;
8(8).
PMID: 32756305
Cancer is one of the life-threatening disorders that, in spite of excellent advances in medicine and technology, there is no effective cure for. Surgery, chemotherapy, and radiotherapy are extensively applied...